Anagenex, which mixes AI and large-scale proprietary datasets for drug discovery, has raised a $30M Sequence A led by Catalio Capital Administration (Arundhati Parmar/MedCity Information)

0
8




Arundhati Parmar / MedCity Information:

Anagenex, which mixes AI and large-scale proprietary datasets for drug discovery, has raised a $30M Sequence A led by Catalio Capital Administration  —  The CEO of Anagenex believes that the corporate’s AI engine skilled on billions of knowledge factors and iterative testing will blow different AI drug discovery startups out of the water.



LEAVE A REPLY

Please enter your comment!
Please enter your name here